Lingling Xu

531 total citations
21 papers, 394 citations indexed

About

Lingling Xu is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lingling Xu has authored 21 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lingling Xu's work include MicroRNA in disease regulation (4 papers), Cardiac Fibrosis and Remodeling (4 papers) and Traditional Chinese Medicine Analysis (2 papers). Lingling Xu is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cardiac Fibrosis and Remodeling (4 papers) and Traditional Chinese Medicine Analysis (2 papers). Lingling Xu collaborates with scholars based in China and United States. Lingling Xu's co-authors include Wenjie Li, Baohong Jiang, De‐an Guo, Yanping Deng, Wanying Wu, Fukang Teng, Shuhong Guan, Feng Xu, Jing Chen and Yanhui Wang and has published in prestigious journals such as PLoS ONE, Frontiers in Pharmacology and Lung Cancer.

In The Last Decade

Lingling Xu

20 papers receiving 389 citations

Peers

Lingling Xu
Bingbo Yu China
Jiang Shi-sen China
Chuanhua Yang China
Pauline Mury France
Xiao Ting Lu China
William L. Willis United States
Xingxin Xu China
Jianjie Wang China
Yingqiang Du China
Theodore M. Hill United States
Bingbo Yu China
Lingling Xu
Citations per year, relative to Lingling Xu Lingling Xu (= 1×) peers Bingbo Yu

Countries citing papers authored by Lingling Xu

Since Specialization
Citations

This map shows the geographic impact of Lingling Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingling Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingling Xu more than expected).

Fields of papers citing papers by Lingling Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingling Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingling Xu. The network helps show where Lingling Xu may publish in the future.

Co-authorship network of co-authors of Lingling Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingling Xu. A scholar is included among the top collaborators of Lingling Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingling Xu. Lingling Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Min, Liang Peng, Lingling Xu, et al.. (2025). MICRORNA-146B TARGETS HIF-1Α AND ATTENUATES CARDIOMYOCYTE APOPTOSIS AND FIBROSIS IN DOXORUBICIN-INDUCED HEART FAILURE. Shock. 63(4). 656–663.
2.
Xu, Lingling, Pengfei Wu, Wei Ye, et al.. (2024). Clinical characteristics and prognostic analysis of patients with SMARCA4-deficient lung cancer. Technology and Health Care. 33(2). 1014–1020. 2 indexed citations
3.
Cui, Xi, Lingling Xu, Yizhu Shan, et al.. (2024). Piezocatalytically-induced controllable mineralization scaffold with bone-like microenvironment to achieve endogenous bone regeneration. Science Bulletin. 69(12). 1895–1908. 48 indexed citations
4.
Yuan, Liping, et al.. (2023). Establishment of a nomogram for predicting functional constipation among children in China: Using the Rome IV criteria. Arab Journal of Gastroenterology. 24(4). 204–210. 1 indexed citations
5.
Xu, Lingling, et al.. (2023). circROCK1 Promotes septic myocardial injury through regulating miR-96-5p/OXSR1 axis. Acta Biochimica Polonica. 70(3). 567–574. 3 indexed citations
6.
Cai, Juan, et al.. (2023). SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1/STAT3 pathway in primary Sjögren's syndrome. International Immunopharmacology. 126. 111282–111282. 8 indexed citations
7.
8.
He, Zhiyu, Xiaojun Zeng, Peiying Liu, et al.. (2021). LncRNA Chaer Prevents Cardiomyocyte Apoptosis From Acute Myocardial Infarction Through AMPK Activation. Frontiers in Pharmacology. 12. 649398–649398. 12 indexed citations
9.
Xu, Lingling, Zhangrui Zeng, Yinhuan Ding, et al.. (2021). Distribution and Antimicrobial Susceptibility of Gram-Positive and Gram-Negative Pathogens Isolated from Patients Hospitalized in a Tertiary Teaching Hospital in Southwestern China. Jundishapur Journal of Microbiology. 13(12). 4 indexed citations
10.
Li, Wenjie, et al.. (2020). SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials. Cardiovascular Diabetology. 19(1). 130–130. 105 indexed citations
11.
12.
13.
Wang, Min, Tao Guo, Nan Su, et al.. (2019). MicroRNA-23 inhibition protects the ischemia/reperfusion injury via inducing the differentiation of bone marrow mesenchymal stem cells into cardiomyocytes.. PubMed. 12(3). 1060–1069. 6 indexed citations
14.
Xu, Lingling, et al.. (2018). miR‑149 promotes the myocardial differentiation of mouse bone marrow stem cells by targeting Dab2. Molecular Medicine Reports. 17(6). 8502–8509. 13 indexed citations
15.
Yang, Xiaodong, et al.. (2013). Preparation and antimicrobial effect of aromatic, natural and bacteriostatic foot wash with skin care. China Journal of Chinese Materia Medica. 38(12). 2023–6. 2 indexed citations
16.
Wang, Yanhui, Feng Xu, Jing Chen, et al.. (2011). Matrix metalloproteinase-9 induces cardiac fibroblast migration, collagen and cytokine secretion: Inhibition by salvianolic acid B from Salvia miltiorrhiza. Phytomedicine. 19(1). 13–19. 44 indexed citations
17.
Xu, Lingling, Yanping Deng, Lixin Feng, et al.. (2011). Cardio-Protection of Salvianolic Acid B through Inhibition of Apoptosis Network. PLoS ONE. 6(9). e24036–e24036. 54 indexed citations
18.
Jiang, Baohong, Jing Chen, Lingling Xu, et al.. (2010). Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling. BMC Pharmacology. 10(1). 10–10. 55 indexed citations
19.
Jiang, Baohong, Wanying Wu, Ming Li, et al.. (2009). Cardioprotection and Matrix Metalloproteinase-9 Regulation of Salvianolic Acids on Myocardial Infarction in Rats. Planta Medica. 75(12). 1286–1292. 16 indexed citations
20.
Xu, Lingling. (2003). EFFECT OF CHEMICAL ACTIVITY OF MgO ON CRACKING AND WATER-RESISTANCE OF MAGNESIUM OXYCHLORIDE MATERIALS. Guisuanyan xuebao. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bingbo Yu Breakdown of academic impact, for papers by Jiang Shi-sen Breakdown of academic impact, for papers by Chuanhua Yang Breakdown of academic impact, for papers by Pauline Mury Breakdown of academic impact, for papers by Xiao Ting Lu Breakdown of academic impact, for papers by William L. Willis Breakdown of academic impact, for papers by Xingxin Xu Breakdown of academic impact, for papers by Jianjie Wang Breakdown of academic impact, for papers by Yingqiang Du Breakdown of academic impact, for papers by Theodore M. Hill
Rankless by CCL
2026